TOPS-MODE approach for the prediction of blood-brain barrier permeation

被引:42
作者
Cabrera, MA [1 ]
Bermejo, M
Pérez, M
Ramos, R
机构
[1] Cent Univ Las Villas, Ctr Chem Bioact, Drug Design Dept, Santa Clara 54830, Villa Clara, Cuba
[2] Univ Valencia, Dept Pharm & Pharmaceut Technol, E-46100 Valencia, Spain
[3] Expt Sugar Cane Stn, Villa Clara 53100, Cuba
[4] Cent Univ Las Villas, Dept Chem & Pharm, Santa Clara 54830, Villa Clara, Cuba
关键词
TOPS-MODE; blood-brain barrier permeation; logBB prediction; in silico;
D O I
10.1002/jps.20081
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The blood-brain barrier permeation has been investigated by using a topological substructural molecular design approach (TOPS-MODE). A linear regression model was developed to predict the in vivo blood-brain partitioning coefficient on a data set of 119 compounds, treated as the logarithm of the blood-brain concentration ratio. The final model explained the 70% of the variance and it was validated through the use of an external validation set (33 compounds of the 119, MAE= 0.33), a leave-one-out crossvalidation (q(2) = 0.65, S-press = 0.43), fivefold full crossvalidation (removing 28 compounds in each cycle, MAE = 33, RMSE = 0.43) and the prediction of +/- values for an external test set (85.7% of good prediction). This methodology evidenced that the hydrophobicity increase the blood-brain barrier permeation, while the polar surface and its interaction with the atomic mass of compounds decrease it; suggesting the capacity of the TOPS-MODE descriptors to estimate brain penetration potential of new drug candidates. Finally, by the present approach, positive and negative substructural contributions to the brain permeation were identified, and their possibilities in the lead generation and optimization processes were evaluated. (C) 2004 Wiley-Liss, Inc. and the American Pharmacists Association.
引用
收藏
页码:1701 / 1717
页数:17
相关论文
共 56 条
[1]  
Abraham M H, 1995, Drug Des Discov, V13, P123
[2]   On the partition of ampholytes: Application to blood-brain distribution [J].
Abraham, MH ;
TakacsNovak, K ;
Mitchell, RC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (03) :310-315
[3]   HYDROGEN-BONDING .33. FACTORS THAT INFLUENCE THE DISTRIBUTION OF SOLUTES BETWEEN BLOOD AND BRAIN [J].
ABRAHAM, MH ;
CHADHA, HS ;
MITCHELL, RC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (09) :1257-1268
[4]  
[Anonymous], LIPOPHILICITY DRUG A
[5]  
[Anonymous], MODESLAB 1 0 MOL DES
[6]   Predicting blood-brain transport of drugs: A computational approach [J].
Basak, SC ;
Gute, BD ;
Drewes, LR .
PHARMACEUTICAL RESEARCH, 1996, 13 (05) :775-778
[7]   Stereoselective passage of mefloquine through the blood-brain barrier in the rat [J].
Baudry, S ;
Pham, YT ;
Baune, B ;
Vidrequin, S ;
Crevoisier, C ;
Gimenez, F ;
Farinotti, R .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1997, 49 (11) :1086-1090
[8]   ANIMAL-MODELS FOR STUDYING TRANSPORT ACROSS THE BLOOD-BRAIN-BARRIER [J].
BONATE, PL .
JOURNAL OF NEUROSCIENCE METHODS, 1995, 56 (01) :1-15
[9]   VAN DER WAALS VOLUMES + RADII [J].
BONDI, A .
JOURNAL OF PHYSICAL CHEMISTRY, 1964, 68 (03) :441-+
[10]  
Calder J A, 1994, Drug Des Discov, V11, P259